Journals / Turkish Journal of Gastroenterology / 2019 / Cilt: 30 - Sayı: 12

Population-based assessment of gastrointestinal symptoms and diseases: Cappadocia Cohort, Turkey

Pages
1009–1020
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Special attention must be paid to these diseases while planning health policies and reimbursements.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aims: The aim of this study was to determine the prevalence of symptoms and diseases of the lower and upper gastrointestinal system (GIS) in a population-based sample.Materials and Methods: The cross-sectional cohort study was conducted in Cappadocia cohort comprising the Gülşehir and Avanosdistricts.
📊
Key Findings & Data:The “Gastrointestinal Symptom Questionnaire” was applied to persons over the age of 18 years.Results: The GI Symptom Questionnaire was applied to 3369 subjects, and height and body weight were measured in 2797 consentingsubjects.
💡
Conclusion & Impact:Special attention must be paid to these diseases while planning health policies and reimbursements.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background/Aims: The aim of this study was to determine the prevalence of symptoms and diseases of the lower and upper gastrointestinal system (GIS) in a population-based sample.Materials and Methods: The cross-sectional cohort study was conducted in Cappadocia cohort comprising the Gülşehir and Avanosdistricts. The “Gastrointestinal Symptom Questionnaire” was applied to persons over the age of 18 years.Results: The GI Symptom Questionnaire was applied to 3369 subjects, and height and body weight were measured in 2797 consentingsubjects. Of the participants, 61% were female and the mean patient age was 50±15 years. At least one GI symptom was present in70.6% of the cohort. The most common upper GI symptoms were gastric bloating (31.0%) and heartburn (29.1%). The most commonlower GI symptom was abnormal defecation (33.5). The prevalence of upper GIS and lower GIS diseases was 32.7% and 12.9%, respectively, and the prevalence of togetherness of upper and lower GIS diseases was 9.9%. Prevalence of GIS disease was approximately 3times higher in females (p<0.001). All of the upper and lower GI symptoms and the prevalence of upper GIS disease increased in line withBody mass index (BMI).Conclusion: This first population-based, cross-sectional cohort study revealed that the prevalence of GIS diseases is critically high foroptimal public health. Special attention must be paid to these diseases while planning health policies and reimbursements.

🔖

Cite This Article

SEZGİN, O., AKPINAR, H., ÖZER, B., TÖRÜNER, M., BAL, K., BOR, S. (2019). Population-based assessment of gastrointestinal symptoms and diseases: Cappadocia Cohort, Turkey. Turkish Journal of Gastroenterology, Cilt: 30 - Sayı: 12, 1009–1020. https://ajindex.com/articles/408813

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Tezel A, Dökmeci G, Eskiocak M, Umit H, Soylu AR. Epidemiological features of ulcerative colitis in Trakya, Turkey. J Int Med Res 2003
  2. [CrossRef] 2. Ozin Y, Kilic MZ, Nadir I, Cakal B, Disibeyaz S, Arhan M, Dagli U, Tunc B, Ulker A, Sahin B. Clinical features of ulcerative colitis and Crohn’s disease in Turkey. J Gastrointestin Liver Dis 2009
  3. Bor S, Sarıtaş Yüksel E. How is the gastroesophageal reflux disease prevalence, incidence, and frequency of complications (stricture/esophagitis/Barrett’s esophagus/carcinoma) in Turkey compared to other geographical regions globally? Turk J Gastroenterol 2017
  4. 28(Suppl 1): S4-S9. [CrossRef] 4. Bor S, Kitapcioglu G, Kasap E. Prevalence of gastroesophageal reflux disease in a country with a high occurrence of Helicobacter pylori. World J Gastroenterol 2017
  5. [CrossRef] 5. Orhan Sezgin, Bünyamın Sarıtaş, İsmaıl Aydın, Tayyar Şaşmaz, Ebru Serınsöz Linke. Celıac Dısease Prevalence In Turkey: A Populatıon Based Cross-Sectıonal Study. Acta Medica Mediterranea 2016
  6. Knill-Jones RP: Geographical differences in the prevalence of dyspepsia. Scand J Gastroenterol 1991
  7. 26(Suppl 182): 17-24. [CrossRef] 7. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012
  8. [CrossRef] 8. Ünal S, Aşcıoğlu S, Demirkazık A, et al. Baseline data of a prospective cohort study. Cappadocia cohort study, Turkey. Turk J Public Health 2018
  9. Bovenschen HJ, Janssen MJR, van Oijen MGH, et al. Evaluation of a Gastrointestinal Symptoms Questionnaire. Dig Dis Sci 2006
  10. [CrossRef] 10. Locke GR, Zinsmeister AR, Fett SL, Melton LJ, Talley NJ. Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil 2005
  11. [CrossRef] 11. Almario CV, Ballal ML, Chey WD, et al. Burden of Gastrointestinal Symptoms in the united States: results of a nationally representative Survey of over 71,000 Americans. Am J Gastroenterol 2018
  12. [CrossRef] 12. Kitapçioğlu G, Mandiracioğlu A, Caymaz Bor C, Bor S. Overlap of symptoms of dyspepsia and gastroesophageal reflux in the community. Turk J Gastroenterol 2007
  13. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, et al. U.S. householder survey of functional gastrointestinal diseases. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993
  14. [CrossRef] 14. Agreus L, Svardsu